Ac Immune Sa (ACIU) Annual Balance Sheets

Annual · GAAP · USD millions
Access ACIU quarterly Balance Sheets →
Quarterly balance sheet trends provide context on Ac Immune Sa's liquidity, leverage, and long-term financial structure.
Annual Report, GAAP in USD millions
ITEM
(Dec 31 2025)
(Dec 31 2024) (Dec 31 2023) (Dec 31 2022) (Dec 31 2021)
Assets
Cash And Cash Equivalents33.76
Cash & Short-term Investments33.00
Accounts receivable0.00
Other Current Assets69.93
Total Current Assets121.88
Equipment/Property/Plant Net2.51
Intangible Assets63.53
Other Assets, Noncurrent55.54
Shortterm Deposits Not Classified As Cash Equivalents64.62
Noncurrent Assets-
Current Prepaid Expenses-
Current Accrued Income Including Current Contract Assets-
Other Current Receivables-
Total Assets194.37
Liabilities
Accounts Payable2.61
Other Liabilities, Current94.69
Total Current Liabilities119.32
Total Long-term Debt0.00
Other liabilities, Noncurrent14.67
Total Liabilities137.81
Stockholders' Equity
Other Equity44.88
Common Stockholder's Equity44.88
Total Stockholder's Equity56.56
Liabilities & Stockholder's Equity194.37
4 historic quarters locked

Sign in to unlock the full Ac Immune Sa balance sheet history.

About Ac Immune Sa Annual Balance Sheet

What this statement shows

This page presents issuer-reported balance sheet data, detailing assets, liabilities, and stockholders equity as reported in SEC 20-F filings and standardized by CSIMarket. The balance sheet reflects the company's financial position at the end of each reporting period.

Source & verification

Last updated

  • Page updated:
  • Data lineage: SEC filings - XBRL extraction - balance-sheet normalization in the CSIMarket.com financial database.
  • Accession: 0001104659-26-027342

Balance sheet figures represent financial position at specific reporting dates and may be revised in subsequent filings.

Get the full CSIMarket dataset: Subscribe API License